The hepatitis B vaccine dramatically reduces childhood infections—so why is there opposition?
The hepatitis B vaccine has significantly reduced the number of childhood infections globally. However, regardless of its proven efficiency, certain groups still express doubt or refuse its application. When the hepatitis B vaccine was launched, it marked a milestone in the battle against a virus that had caused numerous chronic infections and associated issues such as liver ailments and cancer. Through time, research consistently demonstrated that this preventive approach is among the most effective public health methods available. In nations where vaccination programs have been extensively carried out, infection rates among children have decreased substantially, providing protection to future generations…